|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300073360 |
|
最近更新日期: Date of Last Refreshed on: |
2023-07-07 16:38:09 |
|
注册时间: Date of Registration: |
2023-07-07 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
改善癌症患者及其未成年子女家庭沟通及其社会心理健康的家庭谈话干预的文化调适及应用研究 |
|
Public title: |
Family Talk Intervention for Improving Psychosocial wellbeing of Patients with Advanced Cancer and Their Dependent Children: A Clinical Trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
改善癌症患者及其未成年子女家庭沟通及其社会心理健康的家庭谈话干预 |
|
Scientific title: |
Family Talk Intervention for Improving Psychosocial wellbeing of Patients with Advanced Cancer and Their Dependent Children |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
焦晶晶 |
研究负责人: |
焦晶晶 |
|
Applicant: |
Jiao Jingjing |
Study leader: |
Jiao Jingjing |
|
申请注册联系人电话: Applicant telephone: |
+86 137 8619 9539 |
研究负责人电话: Study leader's telephone: |
+86 137 8619 9539 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
395994525@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
395994525@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖南省长沙市岳麓区桐梓坡路172号湘雅医学院 |
研究负责人通讯地址: |
湖南省长沙市岳麓区桐梓坡路172号湘雅医学院 |
|
Applicant address: |
No. 172 Tongzipo Road, Changsha, Hunan 410013 China |
Study leader's address: |
No. 172 Tongzipo Road, Changsha, Hunan 410013 China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中南大学湘雅护理学院 |
||
|
Applicant's institution: |
Xiangya School of Nursing, Central South University |
||
|
研究负责人所在单位: |
中南大学湘雅护理学院 |
||
|
Affiliation of the Leader: |
Xiangya School of Nursing, Central South University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
E202351 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中南大学护理学院行为医学与护理学伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethical Review Board of Behavioral Medicine and Nursing, School of Nursing, Central South University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-03-19 00:00:00 |
||
|
伦理委员会联系人: |
杨敏 |
||
|
Contact Name of the ethic committee: |
YangMin |
||
|
伦理委员会联系地址: |
湖南省长沙市岳麓区桐梓坡路172号湘雅医学院 |
||
|
Contact Address of the ethic committee: |
No. 172 Tongzipo Road, Changsha, Hunan 410013 China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 180 7318 5501 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中南大学湘雅护理学院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Xiangya School of Nursing, Central South University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖南省长沙市岳麓区桐梓坡路172号湘雅医学院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
No. 172 Tongzipo Road, Changsha, Hunan 410013 China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
self-financing |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
cancer |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
通过科学严谨的方法,对家庭谈话干预进行文化调适,确立一套适于本土应用的改善癌症患者及其青少年子女家庭沟通及社会心理健康的家庭谈话干预方案,以提高患癌家庭成员之间的有效沟通和家庭功能,从而减少癌症患者及其青少年子女的心理问题。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
1.To culturally adapt FTI based on psychosocial care needs and preference of the target population. 2. To evaluate the process, barriers, and outcomes of implementing the adapted FTI in the target population. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
(1)癌症患者: |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
(1) Cancer patients: ① Age: over 30 years old; ② diagnosed with cancer by pathology or cytology; ③ AJCC stages II, III, IV; ④ life expectancy judged by the attending physician for> 6 months; ⑤ knows cancer condition; ⑥ can read, write and communicate. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
(1)癌症患者: |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
(1) Cancer patients: ① Anxiety or depression that meet the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (5th Edition) (DSM-5); ② has mental disorders that meet the diagnostic criteria of China Classification and Diagnostic Standards of Mental Disorders (Third Edition); ③ has other serious physical diseases, such as congenital heart disease; ④ is or has participated in other psychosocial interventions.(2) Young children: ① Anxiety or depression that meet the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (5th Edition) (DSM-5); ② with mental disorders that meet the diagnostic criteria of China Classification and Diagnostic Standards of Mental Disorders (Third Edition); ③ with other serious physical diseases, such as congenital heart disease; ④ is or has participated in other psychosocial interventions. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-03-20 00:00:00至 To 2024-03-15 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-03-20 00:00:00 至 To 2024-02-22 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机区组分组。配对的癌症患者及其青少年子女以1:1的比例分配给家庭谈话干预的干预组或常规护理的对照组。首先,本研究将设定A组和B组,在该阶段不能得知A、B组与干预组和对照组的对应情况。本研究拟将区组长度设定为4,因此共包括六种区组排列,即:AABB, ABAB, ABBA, BAAB, BABA, BBAA。仅负责随机分组的研究人员(甲)将这六种区组排列放进按顺序编号为1-6的密封不透明信封中,其中每个信封包含每4对癌症患者及其青少年子女的A、B分组情况。然后,通过计算机生成随机数字表,从中仅保留1-6之间的数字,再按照仅保留1-6之间数字的序列来对应编号为1-6的密封不透明信封。最后,每招募到4对配对的癌症患者及其青少年子女时,按顺序拆开信封进行分组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random block group group. Paired cancer patients and their adolescent children were allocated in a 1:1 ratio to the intervention group of the family talk intervention or the control group of usual care. First, this study will set groups A and B, where the correspondence between groups A and B and |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
单盲法。负责评估干预结果的研究人员(丙)只知道研究对象的序列号,不知道研究对象的分组情况。 |
|
Blinding: |
single blind method. The researcher (C) who evaluated the intervention results knew only the serial number of the subjects and did not the grouping of the subjects. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
电脑记录 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
from computers |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
基于4-6次家庭会议 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
through 4-6 times family meetings |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |